Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

NCT00769613 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

BIOLOGICAL: cytomegalovirus IE-1-specific cytotoxic T lymphocytes
BIOLOGICAL: cytomegalovirus pp65-specific cytotoxic T lymphocytes
BIOLOGICAL: therapeutic allogeneic lymphocytes
GENETIC: polymerase chain reaction
OTHER: flow cytometry
OTHER: immunological diagnostic method
OTHER: laboratory biomarker analysis

Sponsor

Milton S. Hershey Medical Center

Collaborators

[object Object]